NICOX SA (COX.PA) Stock Fundamental Analysis

EPA:COX • FR0013018124

0.579 EUR
0 (-0.52%)
Last: Apr 27, 2023, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Taking everything into account, COX scores 2 out of 10 in our fundamental rating. COX was compared to 78 industry peers in the Biotechnology industry. COX may be in some trouble as it scores bad on both profitability and health. COX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • COX had negative earnings in the past year.
COX.PA Yearly Net Income VS EBIT VS OCF VS FCFCOX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -10M -20M -30M -40M

1.2 Ratios

  • COX has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COX.PA Yearly ROA, ROE, ROICCOX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -10 -20 -30 -40 -50

1.3 Margins

  • COX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
COX.PA Yearly Profit, Operating, Gross MarginsCOX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -20K -40K -60K -80K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • COX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, COX has more shares outstanding
  • The debt/assets ratio for COX is higher compared to a year ago.
COX.PA Yearly Shares OutstandingCOX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
COX.PA Yearly Total Debt VS Total AssetsCOX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -8.19, we must say that COX is in the distress zone and has some risk of bankruptcy.
  • COX's Altman-Z score of -8.19 is on the low side compared to the rest of the industry. COX is outperformed by 69.14% of its industry peers.
  • COX has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • COX has a Debt to Equity ratio of 0.47. This is comparable to the rest of the industry: COX outperforms 54.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z -8.19
ROIC/WACCN/A
WACC6.99%
COX.PA Yearly LT Debt VS Equity VS FCFCOX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M 100M

2.3 Liquidity

  • COX has a Current Ratio of 4.10. This indicates that COX is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 4.10, COX is doing good in the industry, outperforming 75.31% of the companies in the same industry.
  • COX has a Quick Ratio of 4.10. This indicates that COX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.10, COX is in the better half of the industry, outperforming 79.01% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.1
Quick Ratio 4.1
COX.PA Yearly Current Assets VS Current LiabilitesCOX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 47.58% over the past year.
  • COX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -54.78%.
  • Measured over the past years, COX shows a small growth in Revenue. The Revenue has been growing by 7.25% on average per year.
EPS 1Y (TTM)47.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.55%
Revenue 1Y (TTM)-54.78%
Revenue growth 3Y-21.86%
Revenue growth 5Y7.25%
Sales Q2Q%-68.85%

3.2 Future

  • COX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.12% yearly.
  • Based on estimates for the next years, COX will show a small growth in Revenue. The Revenue will grow by 7.81% on average per year.
EPS Next Y35.92%
EPS Next 2Y9.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.23%
Revenue Next 2Y7.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
COX.PA Yearly Revenue VS EstimatesCOX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
COX.PA Yearly EPS VS EstimatesCOX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • COX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year COX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COX.PA Price Earnings VS Forward Price EarningsCOX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COX.PA Per share dataCOX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.12%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for COX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NICOX SA

EPA:COX (4/27/2023, 7:00:00 PM)

0.579

0 (-0.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap28.92M
Revenue(TTM)3.27M
Net Income(TTM)-27.76M
Analysts85
Price Target2.91 (402.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-46.73%
PT rev (3m)-46.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.92%
EPS NY rev (3m)10.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.25%
Revenue NY rev (3m)1.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.84
P/FCF N/A
P/OCF N/A
P/B 0.55
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.07
BVpS1.05
TBVpS-0.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.1
Quick Ratio 4.1
Altman-Z -8.19
F-Score0
WACC6.99%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.55%
EPS Next Y35.92%
EPS Next 2Y9.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-54.78%
Revenue growth 3Y-21.86%
Revenue growth 5Y7.25%
Sales Q2Q%-68.85%
Revenue Next Year16.23%
Revenue Next 2Y7.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year63.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

NICOX SA / COX.PA FAQ

What is the ChartMill fundamental rating of NICOX SA (COX.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to COX.PA.


What is the valuation status of NICOX SA (COX.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to NICOX SA (COX.PA). This can be considered as Overvalued.


How profitable is NICOX SA (COX.PA) stock?

NICOX SA (COX.PA) has a profitability rating of 0 / 10.


What is the earnings growth outlook for NICOX SA?

The Earnings per Share (EPS) of NICOX SA (COX.PA) is expected to grow by 35.92% in the next year.